4.8 Review

Myocyte enhancer factor 2C in hematopoiesis and leukemia

Journal

ONCOGENE
Volume 33, Issue 4, Pages 403-410

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2013.56

Keywords

MEF2C; hematopoiesis; leukemia

Funding

  1. Children Cancer Free Foundation (Stichting Kinderen Kankervrij (KIKA) [2008-029]

Ask authors/readers for more resources

MEF2C is a selectively expressed transcription factor involved in different transcriptional complexes. Originally identified as an essential regulator of muscle development, ectopic expression of MEF2C as a result of chromosomal rearrangements is now linked to leukemia. Specifically, high MEF2C expression has been linked to mixed lineage leukemia-rearranged acute myeloid leukemia as well as to the immature subgroup of T-cell acute lymphoblastic leukemia. This review focuses on the role of MEF2C in the hematopoietic system and on aberrant MEF2C expression in human leukemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available